| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0072 | 1 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.015 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |